Eric Lowe, MD
Children's Hospital of The King's Daughters
Additional Roles
- Professor, Division of Pediatric Hematology/Oncology
- Chief Clinical Academic Officer, Children's Hospital of The King's Daughters
Dr. Eric J. Lowe has practiced at Children’s Hospital of The King’s Daughters (CHKD) as a Pediatric Hematologist/Oncologist since 2004. A graduate of Emory University School of Medicine, Dr. Lowe completed pediatric residency training at the University of Texas Southwestern Medical Center and fellowship training in Pediatric Hematology/Oncology at St. Jude Children’s Research Hospital, where a Master of Science in Clinical Epidemiology was also earned.
Over nearly two decades at CHKD, Dr. Lowe has built a nationally and internationally recognized clinical and research career, including leadership of an international National Cancer Institute clinical trial and becoming a world leader in the treatment of anaplastic large cell lymphoma.
Dr. Lowe has held numerous leadership roles, including Division Director of Pediatric Hematology/Oncology and Vice President of the Children’s Specialty Group, and continues to lead efforts focused on clinical excellence, research expansion, education, and institutional growth.
Education
- Medical School: Emory University
- Residency: Children's Medical Center of Dallas
- Fellowship: St. Jude Children's Research Hospital
Certification
- American Board of Pediatrics
- Pediatric Hematology-Oncology
Dr. Eric J. Lowe is an internationally recognized leader in pediatric hematology/oncology research, with a primary focus on anaplastic large cell lymphoma (ALCL) and non‑Hodgkin lymphoma. Dr. Lowe served as the principal investigator of a multi‑institutional, randomized Phase II clinical trial evaluating novel targeted therapies for newly diagnosed pediatric ALCL. Designed in collaboration with international investigators and industry partners, the study enrolled 137 patients from more than 80 institutions worldwide and represented one of the largest trials conducted in this disease.
The primary outcomes of this trial were published in Blood (2021) and the Journal of Clinical Oncology (2023), with Dr. Lowe as first author on both manuscripts. Dr. Lowe has authored numerous additional peer‑reviewed publications, the majority focused on pediatric non‑Hodgkin lymphoma. Nationally, Dr. Lowe is an active member of the Children’s Oncology Group Non‑Hodgkin Lymphoma Steering Committee and serves as Chair of the Anaplastic Large Cell Lymphoma Subcommittee. Internationally, Dr. Lowe has been appointed Chair of a European Data Safety Monitoring Committee for a lymphoma trial investigating a novel therapeutic agent and is a frequent invited speaker at international scientific meetings, including service on the scientific committee for multiple International Symposia on Non‑Hodgkin Lymphoma.
Specialty (Division)
- Hematology and Oncology